E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Association of fibrinogen, fibrin degradation product, and D-dimer level with disease severity in hospitalized COVID-19 patients – A cross-sectional study in Eastern India

Aparajita Samaddar, Manas Talukdar, Santasmita Pal, Ipsita Saha, Anadi Roy Chowdhury.

Abstract
Background: Although most of the COVID-19 patients presented with mild symptoms and recovered, a considerable number of cases became serious with poor prognosis in an unpredictable manner. They mostly presented with respiratory symptoms and coagulation abnormalities with thrombosis and multi-organ failure. Hence, timely prediction of these cases with the early intervention might decrease mortality.

Aims and Objectives: The objectives of this were to determine whether values of fibrinogen, fibrin degradation products (FDP), and D-dimer level correlates with disease severity in COVID-19 patients.

Materials and Methods: This observational cross-sectional study was done on total 400 hospitalized COVID-19 adult patients where patients were categorized into moderate and severe cases as per guideline of Government of India. Patients with pre-existing coagulation disorder or receiving anticoagulant drugs were excluded from the study. FDP, fibrinogen, and D-dimer values of these two groups were evaluated and compared statistically to determine their significance.

Results: Overall mean and standard deviation of fibrinogen, FDP, and D-dimer were 607.48 ± 177.73, 34.93 ± 29.2, and 6.23 ± 6.48 for severe category, while for moderate category disease, they were 389.77 ± 110.16, 10.79 ± 10.47, and 1.96 ± 3.3, respectively. Unpaired t-test showed that the study parameters are significantly higher in severe COVID-19 patients compared to moderate ones.

Conclusion: It was concluded that elevated level of D-dimer, fibrinogen, and FDP is indicator of disease progression in COVID-19. Thus, regular estimation of these simple coagulation parameters may predict disease severity and help in adequate management.

Key words: COVID-19; Fibrinogen; Fibrin Fibrinogen degradation products; D-dimer; Severity


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Aparajita Samaddar
Articles by Manas Talukdar
Articles by Santasmita Pal
Articles by Ipsita Saha
Articles by Anadi Roy Chowdhury
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Samaddar A, Talukdar M, Pal S, Saha I, Chowdhury AR. Association of fibrinogen, fibrin degradation product, and D-dimer level with disease severity in hospitalized COVID-19 patients – A cross-sectional study in Eastern India. Natl J Physiol Pharm Pharmacol. 2022; 12(5): 639-642. doi:10.5455/njppp.2022.12.03124202221032022


Web Style

Samaddar A, Talukdar M, Pal S, Saha I, Chowdhury AR. Association of fibrinogen, fibrin degradation product, and D-dimer level with disease severity in hospitalized COVID-19 patients – A cross-sectional study in Eastern India. https://www.njppp.com/?mno=103402 [Access: May 02, 2022]. doi:10.5455/njppp.2022.12.03124202221032022


AMA (American Medical Association) Style

Samaddar A, Talukdar M, Pal S, Saha I, Chowdhury AR. Association of fibrinogen, fibrin degradation product, and D-dimer level with disease severity in hospitalized COVID-19 patients – A cross-sectional study in Eastern India. Natl J Physiol Pharm Pharmacol. 2022; 12(5): 639-642. doi:10.5455/njppp.2022.12.03124202221032022



Vancouver/ICMJE Style

Samaddar A, Talukdar M, Pal S, Saha I, Chowdhury AR. Association of fibrinogen, fibrin degradation product, and D-dimer level with disease severity in hospitalized COVID-19 patients – A cross-sectional study in Eastern India. Natl J Physiol Pharm Pharmacol. (2022), [cited May 02, 2022]; 12(5): 639-642. doi:10.5455/njppp.2022.12.03124202221032022



Harvard Style

Samaddar, A., Talukdar, . M., Pal, . S., Saha, . I. & Chowdhury, . A. R. (2022) Association of fibrinogen, fibrin degradation product, and D-dimer level with disease severity in hospitalized COVID-19 patients – A cross-sectional study in Eastern India. Natl J Physiol Pharm Pharmacol, 12 (5), 639-642. doi:10.5455/njppp.2022.12.03124202221032022



Turabian Style

Samaddar, Aparajita, Manas Talukdar, Santasmita Pal, Ipsita Saha, and Anadi Roy Chowdhury. 2022. Association of fibrinogen, fibrin degradation product, and D-dimer level with disease severity in hospitalized COVID-19 patients – A cross-sectional study in Eastern India. National Journal of Physiology, Pharmacy and Pharmacology, 12 (5), 639-642. doi:10.5455/njppp.2022.12.03124202221032022



Chicago Style

Samaddar, Aparajita, Manas Talukdar, Santasmita Pal, Ipsita Saha, and Anadi Roy Chowdhury. "Association of fibrinogen, fibrin degradation product, and D-dimer level with disease severity in hospitalized COVID-19 patients – A cross-sectional study in Eastern India." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 639-642. doi:10.5455/njppp.2022.12.03124202221032022



MLA (The Modern Language Association) Style

Samaddar, Aparajita, Manas Talukdar, Santasmita Pal, Ipsita Saha, and Anadi Roy Chowdhury. "Association of fibrinogen, fibrin degradation product, and D-dimer level with disease severity in hospitalized COVID-19 patients – A cross-sectional study in Eastern India." National Journal of Physiology, Pharmacy and Pharmacology 12.5 (2022), 639-642. Print. doi:10.5455/njppp.2022.12.03124202221032022



APA (American Psychological Association) Style

Samaddar, A., Talukdar, . M., Pal, . S., Saha, . I. & Chowdhury, . A. R. (2022) Association of fibrinogen, fibrin degradation product, and D-dimer level with disease severity in hospitalized COVID-19 patients – A cross-sectional study in Eastern India. National Journal of Physiology, Pharmacy and Pharmacology, 12 (5), 639-642. doi:10.5455/njppp.2022.12.03124202221032022